X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Sun Pharma with Unichem Lab - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs UNICHEM LAB - Comparison Results

SUN PHARMA    Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUN PHARMA UNICHEM LAB SUN PHARMA/
UNICHEM LAB
 
P/E (TTM) x 41.0 25.0 164.4% View Chart
P/BV x 3.3 2.4 140.4% View Chart
Dividend Yield % 0.7 1.1 64.0%  

Financials

 SUN PHARMA   UNICHEM LAB
EQUITY SHARE DATA
    SUN PHARMA
Mar-17
UNICHEM LAB
Mar-17
SUN PHARMA/
UNICHEM LAB
5-Yr Chart
Click to enlarge
High Rs842320 263.2%   
Low Rs572221 259.0%   
Sales per share (Unadj.) Rs131.6167.2 78.7%  
Earnings per share (Unadj.) Rs32.712.0 273.5%  
Cash flow per share (Unadj.) Rs38.016.9 224.3%  
Dividends per share (Unadj.) Rs3.503.00 116.7%  
Dividend yield (eoy) %0.51.1 44.6%  
Book value per share (Unadj.) Rs152.7117.0 130.5%  
Shares outstanding (eoy) m2,399.2690.88 2,640.0%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x5.41.6 332.2%   
Avg P/E ratio x21.622.6 95.6%  
P/CF ratio (eoy) x18.616.0 116.6%  
Price / Book Value ratio x4.62.3 200.4%  
Dividend payout %10.725.1 42.7%   
Avg Mkt Cap Rs m1,696,87724,578 6,903.9%   
No. of employees `00017.55.2 337.6%   
Total wages/salary Rs m49,0232,487 1,970.9%   
Avg. sales/employee Rs Th18,028.32,928.3 615.7%   
Avg. wages/employee Rs Th2,798.8479.4 583.9%   
Avg. net profit/employee Rs Th4,479.5209.4 2,138.8%   
INCOME DATA
Net Sales Rs m315,78415,195 2,078.2%  
Other income Rs m6,232110 5,654.7%   
Total revenues Rs m322,01615,305 2,104.0%   
Gross profit Rs m100,8931,788 5,643.1%  
Depreciation Rs m12,648452 2,799.4%   
Interest Rs m3,99834 11,863.5%   
Profit before tax Rs m90,4791,413 6,405.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m990-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m12,116326 3,718.8%   
Profit after tax Rs m78,4621,087 7,219.6%  
Gross profit margin %31.911.8 271.5%  
Effective tax rate %13.423.1 58.1%   
Net profit margin %24.87.2 347.4%  
BALANCE SHEET DATA
Current assets Rs m329,5376,426 5,128.1%   
Current liabilities Rs m178,8703,917 4,566.1%   
Net working cap to sales %47.716.5 289.0%  
Current ratio x1.81.6 112.3%  
Inventory Days Days7968 116.7%  
Debtors Days Days8377 108.1%  
Net fixed assets Rs m204,7667,410 2,763.5%   
Share capital Rs m2,399182 1,319.7%   
"Free" reserves Rs m363,99710,454 3,481.7%   
Net worth Rs m366,39710,636 3,444.8%   
Long term debt Rs m14,3614 326,381.8%   
Total assets Rs m614,10215,258 4,024.9%  
Interest coverage x23.642.9 55.1%   
Debt to equity ratio x00 9,474.6%  
Sales to assets ratio x0.51.0 51.6%   
Return on assets %13.47.3 182.8%  
Return on equity %21.410.2 209.6%  
Return on capital %24.813.6 182.7%  
Exports to sales %024.1 0.0%   
Imports to sales %04.9 0.0%   
Exports (fob) Rs mNA3,666 0.0%   
Imports (cif) Rs mNA752 0.0%   
Fx inflow Rs m44,1185,298 832.7%   
Fx outflow Rs m24,4840-   
Net fx Rs m19,6345,298 370.6%   
CASH FLOW
From Operations Rs m70,822683 10,363.2%  
From Investments Rs m-42,216-1,316 3,209.1%  
From Financial Activity Rs m-22,854592 -3,859.2%  
Net Cashflow Rs m6,107-40 -15,305.0%  

Share Holding

Indian Promoters % 63.7 50.1 127.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 5.1 15.1 34.0%  
FIIs % 23.0 3.0 766.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 8.3 31.7 26.2%  
Shareholders   133,026 20,176 659.3%  
Pledged promoter(s) holding % 0.5 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUN PHARMA With:   ALKEM LABORATORIES  PLETHICO PHARMA  WOCKHARDT LTD.  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare SUN PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens 145 Points Up; Sun Pharma Rallies on Strong Earnings(09:30 am)

Asian share markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is flat while the Hang Seng is up 0.7%.

Related Views on News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Beware the 5th year of the Modi Regime(The Honest Truth)

May 22, 2018

2017 was a great year for the market. You were rewarded for taking excessive risk. But Ajit Dayal believes 2018 will be different. You will be rewarded for doing the opposite. Read on to know more...

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


May 28, 2018 10:45 AM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUN PHARMA WITH

MARKET STATS